AI use in federal health agencies has been garnering increasing interest due to its potential to expedite processes and ...

Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...

Diabetes mellitus is associated with worse RCC outcomes across all outcomes. Metformin use was associated with improved outcomes, but this association is likely substantially affected by time-related ...

For patients with stage T1a renal cell carcinoma (T1a RCC), ablation seems to be as effective as resection or nephrectomy, according to a study published online March 3 in Radiology. Johanne ...

School-based cohort had lower risk for cervical cancer compared with the opportunistic cohort after adjustment for covariates ...

In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS ...

Capivasertib+abiraterone was associated with more symptomatic AEs but did not impact HRQoL in patients with PTEN-deficient ...

The combination of tislelizumab and chemotherapy produced sustained and clinically meaningful survival benefits with manageable toxicity among patients ...

Adding LAG-3 or TIGIT ICIs to enfortumab vedotin + pembrolizumab did not improve efficacy in pts with locally advanced or ...

In this analysis, study researchers aimed to assess the association between county-level proximity to nuclear power plants and cancer mortality.

In this study, researchers aimed to determine whether overall survival is superior with first-line CDK4/6i use compared to second-line use in HR-positive, HER-negative advanced breast cancer.

In this study, researchers aimed to fill gaps in the knowledge of treatment management and outcomes in melanoma patients aged 75 years and older.